|
|
Volumn 52, Issue 2, 1995, Pages 151-163
|
|
Projecting future drug expenditures - 1995
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE;
ALBUNEX;
ALENDRONIC ACID;
AMIFOSTINE;
AMPHOTERICIN B;
AMPHOTERICIN B CHOLESTEROL SULFATE;
CARMUSTINE;
CEFACLOR;
DAUNORUBICIN;
DEXFENFLURAMINE;
DORZOLAMIDE;
FAMCICLOVIR;
GANCICLOVIR;
HEPATITIS A VACCINE;
HEPATITIS VACCINE;
LAMOTRIGINE;
LOSARTAN;
LOSARTAN POTASSIUM;
MANGANESE;
MANGANESE CHLORIDE;
MERCAPTAMINE;
METFORMIN;
METOCLOPRAMIDE;
NAVELBINE;
NEFAZODONE;
SIMETHICONE;
SONORX;
STAVUDINE;
SUMATRIPTAN;
SUMATRIPTAN SUCCINATE;
SURAMIN;
TACROLIMUS;
TENIDAP;
TIRILAZAD;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VIGABATRIN;
DRUG COST;
DRUG INDUSTRY;
DRUG RESEARCH;
HEALTH ECONOMICS;
PRIORITY JOURNAL;
REVIEW;
|
|
EID: 0028908411
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/52.2.151 Document Type: Review |
|
Times cited : (20)
|
|
References (0)
|
